Skip to main content
Premium Trial:

Request an Annual Quote

JMF, NHGRI to Develop Newborn Screening Tests on Affy Platform

NEW YORK, Oct. 5 (GenomeWeb News) - The Jeffrey Modell Foundation, a nonprofit devoted to researching pediatric immunodeficiency disorders, and the National Human Genome Research Institute intend to co-develop a post-natal screen for primary immunodeficiency based on Affymetrix's microarray platform, the three partners said today.

NHGRI will take the lead in developing the test, which will look for a form of DNA that is found in children with healthy immune systems. If the test results are unusual, a second test based on Affy's platform will screen for specific biomarkers associated with immunodeficiency.

JMF will fund the project. A time table for when the tests would become available was not discussed.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.